The Top 10 Highest-Paid Women Executives in Biopharma
Compensation Has Climbed since 2014, yet Gap with Male Counterparts Remains
Growing Antibody Industry in China Sees Major Opportunities
Yet, Challenges Remain as Companies Need More Talent and Resources to Market Globally
Molecular Diagnostics Brings Patients Hope
NGS Advancements Pave the Way for New Drug-Resistance Research
Supplement: CRISPR in the Courthouse
An Interview with Law Professor Jacob Sherkow
For full access to this article login to GEN Select now.
Ways to Arm Antibodies Under Increasing Scrutiny
Researchers Are Reviving the Concept of Immunoconjugate Antibodies
- Recombinant antibodies have reached blockbuster drug status. Herceptin, Avastin, Remicade, and others rack up billions of dollars per year in sales. Almost all the clinically approved antibodies in use today are naked, or unconjugated, antibodies. When participants recently met for the Strategic Research Institute’s “World Antibody Summit,” discussion focused ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.